Haemonetics | HAE - Gross Profit On Sales


Haemonetics reported $202.8M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Baxter International USD 1.14B 251M Jun/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Boston Scientific USD 3.82B 210M Jun/2026
Cerus USD 33.33M 8.66M Dec/2024
Cooper Companies USD 711.9M 23.5M Jun/2026
Fresenius EUR 1.55B 16M Jun/2026
Fresenius Medical Care EUR 1.31B 130.98M Jun/2026
Globus Medical USD 548.17M 51.91M Jun/2026
Haemonetics USD 202.8M 4.59M Jun/2026
ICU Medical USD 235.05M 28.83M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
Medtronic USD 6.36B 355M Jun/2026
Merit Medical Systems USD 215.17M 30.37M Jun/2026
Neogen USD 105.5M 2.3M Jun/2026
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Quidel USD 223.9M 315.7M Jun/2026
ResMed USD 861.22M 29.76M Jun/2026
STAAR Surgical USD 69.73M 868K Jun/2026
Steris USD 684.2M 12.9M Jun/2026
Stryker USD 4.5B 688M Jun/2026
Teleflex USD 331.71M 24.28M Jun/2026
Terumo JPY 178.54B 29.52B Jun/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
US Physical Therapy USD 41.94M 9.19M Jun/2026
Zimmer Biomet Holdings USD 1.36B 149.4M Jun/2026